CCA
DCPH

Childress Capital Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Childress Capital Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46
Closed -$3K – 1017
2020
Q4 		$3K Buy
+46
New +$2.73K ﹤0.01% 936

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Childress Capital Advisors's DCPH Position: Q1 2021 in Review

Childress Capital Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 46 shares — an estimated $3K sold.

Childress Capital Advisors first reported a position in DCPH in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Childress Capital Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 46 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $3K.
  • Childress Capital Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.